Avi Cohen, MD
Pulmonary Disease · Detroit, MINPI 1003173667
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $36,400 of the $58,894 with a category attached, or 61.8%. Pulmonx Corporation accounts for 67.3% of it on its own, with 7 other manufacturers making up the rest. Among pulmonary disease clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 103 payments — averaging $571.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pulmonx Corporation$40K
- Intuitive Surgical$17K
- KARL Storz Endoscopy-america$2K
- Merit Medical Systems Inc$700
- Boston Scientific$187
- Bard Peripheral Vascular, Inc.$37
- plus $47 from 2 others
Across 15 payments — averaging $1852.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pulmonx Corporation$28K
What the payments were for
- Consulting fees$36,40062%
- Speaking & faculty fees$8,80015%
- Travel & lodging$5,3329%
- Food & beverage$3,6136%
- Education$4,7508%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pulmonx Corporation | 68 | $39,609 |
| Intuitive Surgical | 24 | $16,794 |
| KARL Storz Endoscopy-america | 3 | $1,520 |
| Merit Medical Systems Inc | 2 | $700 |
| Boston Scientific | 3 | $187 |
| Bard Peripheral Vascular, Inc. | 1 | $37 |
| Olympus Corporation Of The Americas | 1 | $26 |
| Ambu Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZEPHYR ENDOBRONCHIAL VALVE$38,476
- CHARTIS CATHETER$22,526
- ZEPHYR DELIVERY CATHETER$22,526
- PULMONX CHARTIS TABLET CONSOLE$22,526
- DA VINCI SP$9,400
- Da Vinci Surgical System$6,789
How this compares
$58,894 in reported general payments places this provider in the 95th percentile of 463 pulmonary disease providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 47 | $30,965 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 16 | $7,440 |
| Incruse ElliptaUmeclidinium Bromide | 13 | $5,334 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 24 | $734 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Detroit
- Michael SimoffDetroit$149K
- Labib Gilles DebianeDetroit$22K
- Meilan HanAnn Arbor$779K
- Njira LugogoAnn Arbor$741K
- Gustavo Cumbo NacheliGrand Rapids$724K
- Gary FergusonLivonia$601K
- Justin OldhamAnn Arbor$392K
- Mounir GhaliWyoming$371K
- Kevin FlahertyAnn Arbor$328K
- Podduturu ReddyPort Huron$324K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.